Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Tobramycin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tobramycin sulfate and what is the scope of tobramycin sulfate freedom to operate?

Tobramycin sulfate
is the generic ingredient in four branded drugs marketed by Teva Pharms Usa, Lilly, Mylan Labs Ltd, Hospira, West-ward Pharms Int, X Gen Pharms, Igi Labs Inc, Fresenius Kabi Usa, Apothecon, Watson Labs Inc, Claris, Akorn, and Xellia Pharms Aps, and is included in thirty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for tobramycin sulfate. Nine suppliers are listed for this compound.

Summary for Generic Name: tobramycin sulfate

Drug Master File Entries: see list18
Suppliers / Packagers: see list9
Bulk Api Vendors: see list68
Clinical Trials: see list299
Patent Applications: see list7,188
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tobramycin sulfate at DailyMed

Pharmacology for Ingredient: tobramycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
tobramycin sulfate
INJECTABLE;INJECTION064026-001May 31, 1994DISCNNoNo► Subscribe► Subscribe
tobramycin sulfate
INJECTABLE;INJECTION063081-003Jul 31, 1990RXNoYes► Subscribe► Subscribe
West-ward Pharms Int
tobramycin sulfate
INJECTABLE;INJECTION063127-001Nov 27, 1991DISCNNoNo► Subscribe► Subscribe
tobramycin sulfate
INJECTABLE;INJECTION050477-005Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Fresenius Kabi Usa
tobramycin sulfate
INJECTABLE;INJECTION065122-001Nov 29, 2002APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus